Citadel Advisors’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.41M Buy
638,706
+522,025
+447% +$1.15M ﹤0.01% 2991
2025
Q1
$135K Sell
116,681
-805,335
-87% -$934K ﹤0.01% 5037
2024
Q4
$1.17M Buy
922,016
+572,766
+164% +$727K ﹤0.01% 3113
2024
Q3
$1.19M Buy
349,250
+127,916
+58% +$436K ﹤0.01% 2956
2024
Q2
$1.03M Sell
221,334
-494,583
-69% -$2.31M ﹤0.01% 3002
2024
Q1
$5.31M Sell
715,917
-184,716
-21% -$1.37M ﹤0.01% 1724
2023
Q4
$9.12M Buy
900,633
+535,223
+146% +$5.42M ﹤0.01% 1277
2023
Q3
$2.85M Buy
365,410
+30,306
+9% +$236K ﹤0.01% 2073
2023
Q2
$2.76M Sell
335,104
-1,287,715
-79% -$10.6M ﹤0.01% 2172
2023
Q1
$11.8M Buy
1,622,819
+803,436
+98% +$5.82M ﹤0.01% 1203
2022
Q4
$7.27M Sell
819,383
-75,488
-8% -$670K ﹤0.01% 1506
2022
Q3
$11M Sell
894,871
-362,299
-29% -$4.43M ﹤0.01% 1204
2022
Q2
$14.9M Buy
1,257,170
+673,181
+115% +$7.96M ﹤0.01% 1014
2022
Q1
$11.1M Sell
583,989
-296,195
-34% -$5.63M ﹤0.01% 1318
2021
Q4
$23.4M Buy
880,184
+139,676
+19% +$3.71M ﹤0.01% 846
2021
Q3
$30.4M Buy
740,508
+538,763
+267% +$22.1M 0.01% 667
2021
Q2
$11.4M Sell
201,745
-55,276
-22% -$3.13M ﹤0.01% 1340
2021
Q1
$10.8M Buy
257,021
+215,869
+525% +$9.07M ﹤0.01% 1377
2020
Q4
$2.89M Sell
41,152
-145,594
-78% -$10.2M ﹤0.01% 2222
2020
Q3
$5.24M Buy
186,746
+153,822
+467% +$4.32M ﹤0.01% 1482
2020
Q2
$974K Sell
32,924
-25,048
-43% -$741K ﹤0.01% 2883
2020
Q1
$1.15M Sell
57,972
-96,611
-62% -$1.92M ﹤0.01% 2728
2019
Q4
$4.58M Buy
154,583
+23,872
+18% +$707K ﹤0.01% 1696
2019
Q3
$2.97M Sell
130,711
-186,315
-59% -$4.24M ﹤0.01% 2042
2019
Q2
$7.84M Buy
317,026
+268,764
+557% +$6.65M ﹤0.01% 1338
2019
Q1
$1.18M Sell
48,262
-15,968
-25% -$390K ﹤0.01% 2705
2018
Q4
$1.46M Buy
64,230
+22,958
+56% +$522K ﹤0.01% 2479
2018
Q3
$1.31M Sell
41,272
-46,824
-53% -$1.49M ﹤0.01% 2503
2018
Q2
$3.16M Buy
+88,096
New +$3.16M ﹤0.01% 1777
2018
Q1
Hold
0
4058
2017
Q4
Hold
0
3943
2017
Q3
Sell
-40,218
Closed -$675K 3754
2017
Q2
$675K Buy
40,218
+23,951
+147% +$402K ﹤0.01% 2421
2017
Q1
$363K Buy
+16,267
New +$363K ﹤0.01% 2812